Exact(3)
When evaluating HCV prevalence at entry by the time elapsed since start of injection, such prevalence was 59/99 (59.6%) for participants who had injected for less than 2 years before entry vs. 137/164 (82.5%) for participants who had injected for 3 5 years before entry.
Among individuals who had injected for less than 1 year, the adjusted HCV prevalence in 2006 was higher than that in 1992 (28% vs. 19%, respectively).
Sweeting et al. (33) proposed a method for estimating the prevalence of former and current IDUs and reported a substantial 34%9595% CI: 20, 50) proportion of former injectors, who had injected for only a short period, which they defined as less than 1 year.
Similar(56)
Earlier studies showed that younger IDUs who injected with older subgroups or with those who have injected for longer duration were at increased risk of blood-borne infection because of the higher prevalence among the older subgroups [ 15- 17].
To minimize those effects we estimated the incidence only among new injectors, those who have injected for only a short period (3 years), and who would have been very unlikely to have developed AIDS and, given the limited availability of methadone treatment in Tallinn, they would also have been very unlikely to have received methadone treatment.
Among participants who were aware of their HIV infection at time of last intercourse, disclosure was independently associated with (1) the perception that their sex partner was also HIV-positive, (2) the perception that their partner was also an IDU, and (3) the participant having injected for at least 9 years.
Results reveal a comparatively high HCV adjusted prevalence in individuals who have injected for less than 1 year at 19% (95% credible interval: 10, 34) in 1992 approximately halving by 1998 and then increasing to 28%95%5% credible interval: 17, 41) in 2006.
The man, who did not want to be identified because of the stigma surrounding illicit drug use in the Muslim-majority country, said he had injected heroin for seven years before coming to the Ar-Rahman mosque about a year ago.
Ninety-nine patients (67%) had injected drugs for 13 years or more.
An IDU was defined as a person of either sex, aged 18 years or older, who had injected drugs for non-medical reasons at least once in the last 6 months.
But to increase sensitivity, another approach was needed, and MRC clinician scientist Ian Hart, who JND had recruited to Oxford after his PhD with Professor Martin Raff at UCL, developed an indirect immunohistochemical assay using Xenopus oocytes that he had injected with messenger RNAs for the different voltage-gated potassium channel subunits (Supplementary material B193).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com